Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro

Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro

Chronic treatment with the mTOR inhibitor, everolimus, fails long-term in preventing tumor growth and dissemination in cancer patients. Thus, patients experiencing treatment resistance seek complementary measures, hoping to improve therapeutic efficacy. This study investigated metastatic characteris...

Full description

Bibliographic Details
Main Authors: Saira Justin, Jochen Rutz, Sebastian Maxeiner, Felix K.-H. Chun, Eva Juengel, Roman A. Blaheta
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:International Journal of Molecular Sciences
Subjects:
sulforaphane
bladder cancer
adhesion
chemotaxis
integrins
CD44
Online Access:https://www.mdpi.com/1422-0067/21/15/5582

Internet

https://www.mdpi.com/1422-0067/21/15/5582

Similar Items